The Recombinant BID Monoclonal Antibody is a recombinant rabbit monoclonal antibody (clone C310048) against BID. This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2, and thus regulate apoptosis. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Produced by recombinant technology in Rabbit hosts and purified by Protein A affinity chromatography, this Rabbit IgG antibody is reactive against Human samples.
This antibody is suitable for WB, IHC, ICC/IF, FC and IP applications. It has been validated by WB analysis of HCT116, Jurkat, 293T, A431, A549, HepG2, IHC analysis of Human colon cancer and IF analysis of HeLa.
Product Name:
Recombinant BID Monoclonal Antibody
SKU:
RMEA0062
Size:
50 µL, 100 µL
Antibody Type:
Recombinant Monoclonal Antibody
Synonyms:
BH3-Interacting Domain Death Agonist, BID, FP497, p22 BID
Store at -20°C valid for 12 months. Avoid freeze / thaw cycles.
Immunofluorescent analysis of HeLa cells (green), and DAPI (blue).
Immunohistochemical analysis of paraffin-embedded Human colon cancer tissue sections using BID Antibody (RMEA0062) at a dilution of 1:20 (10× lens). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0) for 20 min prior to IHC staining.
Western blot analysis of HCT116,Jurkat,293T,A431,A549 and HepG2 cell lysates using BID Antibody (RMEA0062) at a dilution of 1:1000. Observed-MW:22 kDa Calculated-MW:22 kDa